Clinical evaluation of code-based algorithms to identify patients with pulmonary arterial hypertension in healthcare databases.

"CONFLICTS OF INTEREST STATEMENT EMD and MB are employees of Janssen Pharmaceutical Companies of Johnson & Johnson and own shares of stock/stock options in Johnson & Johnson. RTZ is a consultant to Morphogen‐IX, Vivus, GossamerBio, and Merck; his institution has received research grant support from United Therapeutics, Janssen Pharmaceutical, Merck, Tenax, and Celtaxsys. HH, DL, and AH have no conflict of interest to declare."

"We would like to thank Audrey Muller (Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical company of Johnson & Johnson) for her helpful input into initiating the project and reviewing a draft of the manuscript. This analysis was funded by Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson. Medical writing support was provided by Victoria Atess and Clare Lowe, of Ashfield MedComms, an Inizio company, and funded by Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson."